Last updated 2 months ago

A Study of Lebrikizumab (LY3650150) in Participants 6 Months to <18 Years of Age With Moderate-to-Severe Atopic Dermatitis

300 patients around the world
Available in Argentina, Mexico, United States, Spain
Eli Lilly and Company
24Research sites
300Patients around the world

This study is for people with

Dermatitis
Atopic dermatitis

Requirements for the patient

To 17 Years
All Gender

Medical requirements

Have a diagnosis of AD prior to screening as stated in the criteria by the American Academy of Dermatology for at least: 12 months s if participants are ≥6 years of age, and 6 months if participants are 6 months to <6 years of age. Have an EASI score ≥16 at the screening and baseline. Have an IGA score ≥3 (scale of 0 to 4) at the screening and baseline. Have ≥10% BSA of AD involvement at the screening and baseline.
Are currently enrolled or have participated within the last 8 weeks in a clinical study involving an investigational intervention or any other type of medical research judged not to be scientifically or medically compatible with this study.
Treatment with the following prior to the baseline: An investigational drug within 8 weeks or less than 5 half-lives, whichever is longer. Dupilumab within 8 weeks. Note: The enrollment of participants with prior use of Dupilumab will be limited to <20%. Treatment with a topical investigational drug within 2 weeks prior to the baseline. Have received a Bacillus Calmette-Guerin vaccination or treatment within less than 4 weeks before randomization.

Sites

Centro de Investigaciones Metabólicas (CINME) S.A. - CABA, Buenos Aires
Centro de Investigaciones Metabólicas (CINME) S.A. - CABA, Buenos Aires
Viamonte, Cdad. Autónoma de Buenos Aires, Argentina
Psoriahue Medicina Interdisciplinaria - CABA, Buenos Aires
Psoriahue Medicina Interdisciplinaria - CABA, Buenos Aires
Bulnes 1937, CABA, Buenos Aires
Fundación Respirar
Av. Cabildo 1548, CABA, Buenos Aires
CONEXA Investigación Clínica S.A.
Pasaje Rivarola 111, Piso 3º, Oficina 9, CABA
Fundación CIDEA - Buenos Aires
Fundación CIDEA - Buenos Aires
Paraguay 2035, C1121ABE Cdad. Autónoma de Buenos Aires, Argentina
Instituto Médico de la Fundación Estudios Clínicos - Rosario
Italia 428, Rosario - Santa Fe
Instituto de Neumonología y Dermatología Dr. Luna
Arenales 2557, CABA, Buenos Aires
Universidad Autónoma de Nuevo León, Hospital Universitario Dr. José Eleuterio González
Universidad Autónoma de Nuevo León, Hospital Universitario Dr. José Eleuterio González
Av. Madero y Gonzalitos S/N, Mitras Centro, Monterrey, Nuevo León
Eukarya PharmaSite
De La Clínica 2520, Sertoma, 64718 Monterrey, N.L.
Panamerican Clinical Research S.A. de C.V
Guadalajara, 44670
LinkedinInstagramFacebook
Terms and ConditionsPrivacy Policy